Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

Go back to Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
(NASDAQ: PCVX) Delayed: 51.44 --0 (-0%)
Previous Close $51.44    52 Week High
Open $51.44    52 Week Low
Day High $51.44    P/E N/A 
Day Low $51.44    EPS
Volume 982